“Tanshinone IIA attenuates interleukin-17A-induced systemic sclerosis patient-derived dermal vascular smooth muscle cell activation via inhibition of the extracellular signal-regulated kinase signaling pathway” (2015) Clinics, 70(4), pp. 250–256. doi:10.6061/clinics/2015(04)06.